HAYWARD, Calif., October 10, 2023–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
HAYWARD, Calif., October 10, 2023–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
In